Literature DB >> 29030217

Impact of peripheral immune status on central molecular responses to facial nerve axotomy.

D O Setter1, E M Runge2, N D Schartz3, F M Kennedy2, B L Brown3, K P McMillan2, W M Miller2, K M Shah3, M M Haulcomb2, V M Sanders4, K J Jones2.   

Abstract

When facial nerve axotomy (FNA) is performed on immunodeficient recombinase activating gene-2 knockout (RAG-2-/-) mice, there is greater facial motoneuron (FMN) death relative to wild type (WT) mice. Reconstituting RAG-2-/- mice with whole splenocytes rescues FMN survival after FNA, and CD4+ T cells specifically drive immune-mediated neuroprotection. Evidence suggests that immunodysregulation may contribute to motoneuron death in amyotrophic lateral sclerosis (ALS). Immunoreconstitution of RAG-2-/- mice with lymphocytes from the mutant superoxide dismutase (mSOD1) mouse model of ALS revealed that the mSOD1 whole splenocyte environment suppresses mSOD1 CD4+ T cell-mediated neuroprotection after FNA. The objective of the current study was to characterize the effect of CD4+ T cells on the central molecular response to FNA and then identify if mSOD1 whole splenocytes blocked these regulatory pathways. Gene expression profiles of the axotomized facial motor nucleus were assessed from RAG-2-/- mice immunoreconstituted with either CD4+ T cells or whole splenocytes from WT or mSOD1 donors. The findings indicate that immunodeficient mice have suppressed glial activation after axotomy, and cell transfer of WT CD4+ T cells rescues microenvironment responses. Additionally, mSOD1 whole splenocyte recipients exhibit an increased astrocyte activation response to FNA. In RAG-2-/- + mSOD1 whole splenocyte mice, an elevation of motoneuron-specific Fas cell death pathways is also observed. Altogether, these findings suggest that mSOD1 whole splenocytes do not suppress mSOD1 CD4+ T cell regulation of the microenvironment, and instead, mSOD1 whole splenocytes may promote motoneuron death by either promoting a neurotoxic astrocyte phenotype or inducing Fas-mediated cell death pathways. This study demonstrates that peripheral immune status significantly affects central responses to nerve injury. Future studies will elucidate the mechanisms by which mSOD1 whole splenocytes promote cell death and if inhibiting this mechanism can preserve motoneuron survival in injury and disease.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Axotomy; Motoneuron; Nerve injury; T cells

Mesh:

Substances:

Year:  2017        PMID: 29030217      PMCID: PMC5767532          DOI: 10.1016/j.bbi.2017.10.005

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  72 in total

1.  Lymphocytes reduce nigrostriatal deficits in the 6-hydroxydopamine mouse model of Parkinson's disease.

Authors:  Chi Wang Ip; Sandra K Beck; Jens Volkmann
Journal:  J Neural Transm (Vienna)       Date:  2015-08-20       Impact factor: 3.575

2.  Genomic analysis of reactive astrogliosis.

Authors:  Jennifer L Zamanian; Lijun Xu; Lynette C Foo; Navid Nouri; Lu Zhou; Rona G Giffard; Ben A Barres
Journal:  J Neurosci       Date:  2012-05-02       Impact factor: 6.167

3.  Impaired recruitment of neuroprotective microglia and T cells during acute neuronal injury coincides with increased neuronal vulnerability in an amyotrophic lateral sclerosis model.

Authors:  Mami Fukunaga Kawamura; Ryo Yamasaki; Nobutoshi Kawamura; Takahisa Tateishi; Yuko Nagara; Takuya Matsushita; Yasumasa Ohyagi; Jun-ichi Kira
Journal:  Exp Neurol       Date:  2012-01-24       Impact factor: 5.330

4.  Differential gene expression in the axotomized facial motor nucleus of presymptomatic SOD1 mice.

Authors:  Nichole A Mesnard; Virginia M Sanders; Kathryn J Jones
Journal:  J Comp Neurol       Date:  2011-12-01       Impact factor: 3.215

5.  Immunosuppressive treatment of patients with amyotrophic lateral sclerosis.

Authors:  L Werdelin; G Boysen; T S Jensen; P Mogensen
Journal:  Acta Neurol Scand       Date:  1990-08       Impact factor: 3.209

6.  Comparative evaluation of cytokine profiles and reactive gliosis supports a critical role for interleukin-6 in neuron-glia signaling during regeneration.

Authors:  W J Streit; S D Hurley; T S McGraw; S L Semple-Rowland
Journal:  J Neurosci Res       Date:  2000-07-01       Impact factor: 4.164

7.  Effect of Enrichment Devices on Aggression in Manipulated Nude Mice.

Authors:  Cynthia R Lockworth; Sun-Jin Kim; Jun Liu; Shana L Palla; Suzanne L Craig
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-11       Impact factor: 1.232

8.  Effects of facial nerve axotomy on Th2-associated and Th1-associated chemokine mRNA expression in the facial motor nucleus of wild-type and presymptomatic SOD1 mice.

Authors:  Derek A Wainwright; Nichole A Mesnard; Junping Xin; Virginia M Sanders; Kathryn J Jones
Journal:  J Neurodegener Regen       Date:  2009-09-01

9.  Altered reaction of facial motoneurons to axonal damage in the presymptomatic phase of a murine model of familial amyotrophic lateral sclerosis.

Authors:  R Mariotti; L Cristino; C Bressan; S Boscolo; M Bentivoglio
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

10.  Effects of facial nerve axotomy on Th2- and Th1-associated chemokine expression in the facial motor nucleus of wild-type and presymptomatic mSOD1 mice.

Authors:  Derek A Wainwright; Junping Xin; Nichole A Mesnard; Christine M Politis; Virginia M Sanders; Kathryn J Jones
Journal:  J Neuroimmunol       Date:  2009-10-08       Impact factor: 3.478

View more
  2 in total

1.  CD4+ T cell expression of the IL-10 receptor is necessary for facial motoneuron survival after axotomy.

Authors:  Elizabeth M Runge; Abhirami K Iyer; Deborah O Setter; Felicia M Kennedy; Virginia M Sanders; Kathryn J Jones
Journal:  J Neuroinflammation       Date:  2020-04-17       Impact factor: 8.322

Review 2.  Temporospatial Analysis and New Players in the Immunology of Amyotrophic Lateral Sclerosis.

Authors:  Abhirami K Iyer; Kathryn J Jones; Virginia M Sanders; Chandler L Walker
Journal:  Int J Mol Sci       Date:  2018-02-23       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.